Catalyst Pharmaceuticals (CPRX)
(Delayed Data from NSDQ)
$15.94 USD
+0.29 (1.85%)
Updated May 10, 2024 04:00 PM ET
After-Market: $16.05 +0.11 (0.69%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | 0.45 |
EPS Last Quarter | 0.38 |
Last EPS Surprise | 11.76% |
ABR | 1.00 |
Earnings ESP
|
-8.07% |
---|---|
Current Year | 1.91 |
Next Year | 2.33 |
EPS (TTM) | 1.00 |
P/E (F1) | 8.36 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 111.58M | 120.65M | 460.65M | 541.53M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 113.65M | 124.10M | 465.60M | 579.80M |
Low Estimate | 109.75M | 118.11M | 455.30M | 524.60M |
Year ago Sales | 99.58M | 102.69M | 398.20M | 460.65M |
Year over Year Growth Est. | 12.05% | 17.49% | 15.68% | 17.56% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.45 | 0.53 | 1.91 | 2.33 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | NA | NA | NA | 2.76 |
High Estimate | 0.57 | 0.63 | 2.31 | 2.76 |
Low Estimate | 0.39 | 0.47 | 1.66 | 1.98 |
Year ago EPS | 0.33 | -0.24 | 1.96 | 1.91 |
Year over Year Growth Est. | 36.36% | 320.83% | -2.55% | 22.41% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 3 | 3 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.45 | 0.53 | 1.91 | 2.33 |
7 Days Ago | 0.46 | 0.53 | 1.91 | 2.33 |
30 Days Ago | 0.47 | 0.54 | 1.95 | 2.38 |
60 Days Ago | 0.51 | 0.58 | 2.10 | 2.57 |
90 Days Ago | 0.58 | 0.62 | 2.38 | 2.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.41 | 0.48 | 1.86 | 2.46 |
Zacks Consensus Estimate | 0.45 | 0.53 | 1.91 | 2.33 |
Earnings ESP | -8.07% | -9.43% | -2.41% | 5.26% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.38 | 0.53 | -0.24 | 0.33 | NA |
Estimate | 0.34 | 0.48 | -0.24 | 0.25 | NA |
Difference | 0.04 | 0.05 | 0.00 | 0.08 | 0.04 |
Surprise | 11.76% | 10.42% | 0.00% | 32.00% | 13.55% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more